These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22465544)

  • 1. Opposing effects on the phrenic motor pathway attributed to dopamine-D1 and -D3/D2 receptor activation.
    Lalley PM; Mifflin SW
    Respir Physiol Neurobiol; 2012 Apr; 181(2):183-93. PubMed ID: 22465544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons.
    Lalley PM
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1829-36. PubMed ID: 19279296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine1 receptor agonists reverse opioid respiratory network depression, increase CO2 reactivity.
    Lalley PM
    Respir Physiol Neurobiol; 2004 Feb; 139(3):247-62. PubMed ID: 15122991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
    Gáborján A; Lendvai B; Vizi ES
    Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Rosenzweig-Lipson S; Spealman RD
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes?
    White FJ; Hu XT; Zhang XF
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):91-5. PubMed ID: 9201729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1-dopamine receptor blockade slows respiratory rhythm and enhances opioid-mediated depression.
    Lalley PM
    Respir Physiol Neurobiol; 2005 Jan; 145(1):13-22. PubMed ID: 15652784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
    Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.